Nonalcoholic fatty liver disease (NAFLD), including its more severe manifestation,
nonalcoholic steatohepatitis (NASH), has a global prevalence of 20–25% and is a major …

Lipids are a complex and diverse group of molecules with crucial roles in many
physiological processes, as well as in the onset, progression, and maintenance of cancers …

Immune associated cells in the microenvironment have a significant impact on the
development and progression of hepatocellular carcinoma (HCC) and have received more …

Type 2 diabetes mellitus (T2DM) associated non-alcoholic fatty liver disease (NAFLD) is the
fourth-leading cause of death. Hyperglycemia induces various complications, including …

Background Hepatocellular carcinoma (HCC) ranks the fourth in terms of cancer-related
mortality globally. Herein, in this research, we attempted to develop a novel immune-related …

Cancer is one of the leading causes of mortality worldwide. PPAR modulators may hold
great potential for the management of cancer patients. Indeed, PPARs are critical sensors …

Primary liver cancer (PLC) is one of the most common malignancies in China, where it ranks
second in mortality and fifth in morbidity. Currently, liver transplantation, hepatic tumor …

Background & Aims The pathogenesis of liver fibrosis requires activation of hepatic stellate
cells (HSCs); once activated, HSCs lose intracellular fatty acids but the role of fatty acid …

Bespoken Nanoceria: An Effective Treatment in Experimental H... : Hepatology Bespoken
Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma : Hepatology …

Cell‐fate determination is influenced by interactions between master transcription factors
(TFs) and cis‐regulatory elements. Hepatocyte nuclear factor 4 alpha (HNF4A), a liver …